Yan Moore

Insider Reports History

Entity
Individual
Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Barbara Chan as Attorney-in-Fact for Yan Moore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yan Moore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 110K Feb 7, 2024 Direct

Insider Reports Filed by Yan Moore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Feb 7, 2024 1 $0 4 Feb 9, 2024 Chief Medical Officer
OMGA Omega Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 Chief Medical Officer
OMGA Omega Therapeutics, Inc. Oct 27, 2022 1 $0 4 Oct 28, 2022 Chief Medical Officer
OMGA Omega Therapeutics, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Medical Officer
OMGA Omega Therapeutics, Inc. Jan 3, 2022 0 $0 3 Jan 6, 2022 Chief Medical Officer